Showing results (2541-2550 of 6,970) with videos related to
Sort By:
Pageof 697
Cancer Science|February 11, 2012
Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cellsMonika Toth, Imre M Boros, Eva BalintCancer Science|February 11, 2012
Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabineTomomi Hayashi, Qiang Ding, Taisaku Kuwahata, et al.Cancer Science|February 11, 2012
A new PICTure of nucleolar stressAkira Suzuki, Ryunosuke Kogo, Kohichi Kawahara, et al.Cancer Science|February 11, 2012
Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screenMingli Xu, Masakatsu Takanashi, Kosuke Oikawa, et al.Cancer Science|February 11, 2012
Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppressionLisha Qi, Baocun Sun, Zhiyong Liu, et al.Cancer Science|March 23, 2012
Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti-cancer therapy?Hidemasa Goto, Ichiro Izawa, Ping Li, et al.Cancer Science|March 21, 2012
Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasisYuki Matsumura, Genichiro Ishii, Keiju Aokage, et al.Cancer Science|March 28, 2012
Twists in views on RB functions in cellular signaling, metabolism and stem cellsChiaki Takahashi, Nobunari Sasaki, Shunsuke KitajimaCancer Science|March 28, 2012
Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignanciesMichinori Ogura, Kunihiro Tsukasaki, Hirokazu Nagai, et al.Cancer Science|April 21, 2012
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, et al.Pageof 697